Financial Results

Key highlights

Filter

Period

Filter by

recent search

Showing: 1 – 05 of 23 Financial Results

Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance

Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, today presents its sales performance for the year to date and the third quarter of 2023.


Ipsen delivers solid H1 2023 results and upgrades its full-year guidance
Ipsen delivers solid H1 2023 results and upgrades its full-year guidance

The performance in the first half of the year is reflected in today’s upgrade to our full-year guidance. We look forward to more milestones and further expansion of the pipeline over time through additional external-innovation transactions. I am confident, as…





1 2 3 4 5

Your dedicated contacts